Legal Entity
AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.
Country of registration | Singapore |
Registration number | 200719257W |
Local SIC | |
Incorporation date | 17 Oct 2007 |
Company age | 18 years 7 months |
Official entity type | Private Limited Company |
No. of officers | 5 |
Contact
3 FRASER STREET, #15-26/27, DUO TOWER, Singapore 189352
This is the legal entity page of AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- AMGENView MoreUnited States of AmericaAmgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to and thank you for your assistance.
Fiscal/Budgeting Period | October - December |
Auditor | ERNST & YOUNG LLP |
Revenue | 26m - 50m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | SGD 1,400,001 |
- A. MENARINI BIOMARKERS SINGAPORE

- ABBOTT OPERATIONS SINGAPORE PTE. LTD.

- ALLOZYMES PTE. LTD.

- AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.

- BIOPROCESSING TECHNOLOGY INSTITUTE

- CELLVEC PTE. LTD.

- CSI MEDICAL RESEARCH PRIVATE LIMITED

- DENKA LIFE INNOVATION RESEARCH PTE. LTD.

- EXPERIMENTAL DRUG DEVELOPMENT CENTRE

- FULLERTON HEALTH VERTO

Frequently Asked Questions (FAQ)
- What is the address of AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.?
- Where is AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.'s headquarter?
- What is AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.'s contact number?
- What AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.'s spending power?
- Does AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD. have a presence in the domain it operates in?
